Latest filing published 17 Jun 2025 for Universal Ibogaine Inc., €853.
No signal scores available.
James Andrew Duncan appears in our data through filings on Universal Ibogaine Inc. shares, published by SEDI. Over a trading history stretching from 11 October 2023 to 17 June 2025, the count stands at 2 filings.
Purchases make up the whole of the open-market record (1 purchase, €853). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. So far in 2025, the count stands at 1 purchase and no sales.
Most recently, on 17 June 2025, the filings show an open-market purchase worth €853 in Universal Ibogaine Inc. Source: insider filings from SEDI. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations